| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | EP0287653B1 Hormone receptor compositions and methods |
| 07/14/1999 | CN1222940A Biochemical analysis of antioxidant function |
| 07/14/1999 | CN1222939A Improved transformation method for plants |
| 07/14/1999 | CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1 |
| 07/14/1999 | CN1222934A Plastid transformation in arabidopsis thaliana |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1044133C Process for preparing nucleotide series corresponding to human erythropoietin gene fragment |
| 07/13/1999 | US5922927 Methods for producing tetracycline-regulated transgenic mice |
| 07/13/1999 | US5922854 Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922687 Placing the nucleic acid in an extracellular environment of the cell, defining an enclosure comprising the cell and the extracellular environmenat, establishing an incubation pressure within the enclosure; useful for gene therapy |
| 07/13/1999 | US5922602 This invention is in the field of gene regulation through anti-sense rna endogenously produced inhibitory rna molecules such as anti-sense rna and co-suppressor rna. |
| 07/13/1999 | US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 07/13/1999 | US5922597 The benefit of obtaining a pure population of stem cells is most readily recognized in the field of gene therapy. |
| 07/13/1999 | US5922595 Cyclic GMP phosphodiesterase |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922566 Polynucleotide |
| 07/13/1999 | US5922564 Phosphate-deficiency inducible promoter |
| 07/13/1999 | US5922549 Process for screening substances having a modulating effect on an interleukin-5 receptor mediated cellular signal transmission pathway |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922541 Method for detection of PF4A receptor nucleic acid |
| 07/13/1999 | US5922325 Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | CA2135999C Biotherapeutic cell-coated microspheres |
| 07/08/1999 | WO1999034005A1 Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 07/08/1999 | WO1999033998A2 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 07/08/1999 | WO1999033995A1 Plant galactose dehydrogenase |
| 07/08/1999 | WO1999033994A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | WO1999033993A1 Promoter from ashbya gossypii |
| 07/08/1999 | WO1999033989A2 Rantes mutants and therapeutic applications thereof |
| 07/08/1999 | WO1999033984A1 V197 dna and polypeptides |
| 07/08/1999 | WO1999033983A1 V201 dna and polypeptides |
| 07/08/1999 | WO1999033982A2 Human genes and gene expression products i |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033979A2 Bone marrow secreted proteins and polynucleotides |
| 07/08/1999 | WO1999033972A1 Mammalian edg-5 receptor homologs |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | WO1999033958A2 Desaturase |
| 07/08/1999 | WO1999033956A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | WO1999033955A1 Preparation of cells for production of biologicals |
| 07/08/1999 | WO1999033951A1 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
| 07/08/1999 | WO1999033903A1 Products resulting from the association of elastin derivatives with polymers and/or elastin and their biological applications |
| 07/08/1999 | WO1999033878A1 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 07/08/1999 | WO1999033877A1 V196 dna and polypeptides |
| 07/08/1999 | WO1999033876A1 Novel seven-pass transmembrane receptor protein |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033479A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | WO1999023228B1 Svph1-26 dna and polypeptides |
| 07/08/1999 | WO1999021976A3 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/08/1999 | WO1999016406A3 Therapeutic method |
| 07/08/1999 | WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1998055594A3 Methods for chondrocyte growth and differentiation |
| 07/08/1999 | WO1998035060A8 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof |
| 07/08/1999 | CA2823259A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | CA2317116A1 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
| 07/08/1999 | CA2316990A1 Plant galactose dehydrogenase |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316403A1 Mammalian edg-5 receptor homologs |
| 07/08/1999 | CA2316401A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316282A1 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 07/08/1999 | CA2316080A1 Sex-specific insemination of mammals with low number of sperm cells |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2316016A1 V197 dna and polypeptides |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315879A1 V201 dna and polypeptides |
| 07/08/1999 | CA2315790A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | CA2315702A1 V196 dna and polypeptides |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315534A1 Promoter from ashbya gossypii |
| 07/08/1999 | CA2315297A1 Desaturase |
| 07/08/1999 | CA2240798A1 Method for induction of differentiation of osteoclasts |
| 07/07/1999 | EP0927761A2 Purinebiosynthesis genes from Ashbya possypii and use for the microbial Riboflavinsynthesis |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927354A1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 07/07/1999 | EP0927270A1 Lyophilization of cultured human cells to preserve rna and dna |
| 07/07/1999 | EP0927266A1 THE $i(ESCHERICHIA COLI csrB) GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 07/07/1999 | EP0927263A1 Recombinase-mediated generation of adenoviral vectors |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927246A2 Adenylosuccinate synthetase |
| 07/07/1999 | EP0927245A1 Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts |
| 07/07/1999 | EP0927244A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 07/07/1999 | EP0927193A1 Transformed wheat having improved breadmaking characteristics |
| 07/07/1999 | EP0927052A1 Bladder submucosa seeded with cells for tissue reconstruction |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |